Search
for
Sort by
Research 31–60 of 1000+
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Pharmacotherapy of alopecia areata
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Comparison of Efficacy of Oral Tofacitinib Versus Oral Minoxidil in Patients with Alopecia Areata
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- A review of Janus kinase inhibitor use in scarring alopecia
- Alopecia Areata: Current Treatments and New Directions
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Adjunctive Dupilumab Therapy in a Partial Responder to Baricitinib for Alopecia Areata
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Medical Dermatology
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Janus Kinase inhibitors in dermatology: a review
- An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
- Review of Promising Off-Label Use of Deucravacitinib
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata